“Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5% Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s54. Accessed June 15, 2025. https://skin.dermsquared.com/skin/article/view/998.